Quantum Biopharma QNTM Cash Flow Statement (2018-2026)

NASDAQ QNTM
$2.40 -0.03 (-1.23%)
At close: Oct 21, 2026 · 4:00 PM EDT
Reported Financials

Quantum Biopharma Quarterly Cash Flow Statement

Periods 31 quarters
Latest Jun 2026

Quantum Biopharma reported cash from operations of -$1.79M and free cash flow of -$1.84M for the quarter ended Jun 2026, up 8.2% year over year. This cash flow statement covers 31 quarters of results from Dec 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
5.61M-63.06M5.46M7.97M7.13M-44.16M-9.96M-5.49M-1.13M-1.65M-2.09M-3.35M-4.02M-6.01M-8.74M-9.77M-8.45M-0.24M-13.75M-3.09M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
357.52M355.95M328.30M250.33M
Depreciation & Amortization (CF)Dep. & Amort.
1.00M1.11M1.10M1.13M1.15M1.15M1.13M1.11M0.15M0.12M0.12M0.14M0.12M0.11M0.13M0.14M0.15M0.13M0.13M0.13M
Share-based CompensationStock Comp.
0.25M0.34M0.08M0.36M0.59M0.51M3.21M0.40M0.13M0.10M0.06M0.11M0.07M-0.08M0.29M0.85M1.00M0.81M0.89M0.01M
Cash from Discontinued OperationsCash from Discont. Ops
0.31M-2.61M-0.50M
Gains from Sales and DivestituresGains Divest
-0.18M0.35M
Gains from Investment SecuritiesGains Investment
0.76M-0.88M-0.24M0.18M0.00M-0.49M0.21M0.01M0.28M-0.01M0.07M7.55M0.39M0.10M0.00M0.09M
Asset Writedowns and ImpairmentWritedown
0.09M0.48M3.84M0.24M
Other non-cash itemsOther Non-Cash
6.69M-3.05M7.87M-30.72M-7.76M-3.55M-2.04M12.78M-1.91M-0.01M-2.93M3.12M0.11M-0.01M0.47M12.89M-0.45M
Change in Working Capital
Change in ReceivablesChange Receivables
-0.55M0.31M0.17M-0.53M0.63M-0.48M-0.05M0.05M-0.17M0.01M-0.06M-0.08M0.02M0.27M-0.10M-0.08M-0.11M0.10M-0.02M-0.10M
Change in InventoryChange Inventory
0.12M-0.02M-0.02M753.00-0.03M-665.000.00M
Change in Account PayablesChange Payables
-0.97M0.68M0.44M-0.24M-1.62M0.72M0.61M0.31M0.55M0.58M-1.05M1.03M1.16M3.13M-0.18M0.15M1.42M-0.21M-3.26M4.43M
Change in Other Operating AssetsOther Assets Change
-1.58M1.18M0.20M-0.02M0.04M-1.01M-0.37M0.40M-0.15M-0.19M0.12M-0.14M0.02M-0.08M0.08M0.31M-0.41M-0.02M0.06M-0.02M
Change in Other Operating LiabilitiesOther Liabilities Change
1.00M
Other Working Capital ChangesOther WC Changes
1.58M-1.18M-0.20M0.02M-0.04M1.01M0.37M-0.40M0.15M0.19M-0.12M0.14M0.98M0.08M-0.08M-0.31M0.41M0.02M-0.06M0.02M
Cash from OperationsCash from Ops.
4.59M-37.40M5.09M9.40M7.52M-50.34M-4.75M-3.51M-1.71M-0.85M-1.97M-0.61M-3.46M-0.84M-4.26M-1.95M-1.72M-0.31M-1.67M-1.79M
Investing Activities
Capital ExpendituresCapex
-0.01M0.01M0.01M0.51M0.74M0.02M-222.003.46M3.20M-1.18M1.18M0.46M0.05M
Sales of Property, Plant and EquipmentPP&E (Sale)
0.16M-0.44M0.27M-0.27M2.11M-1.65M0.07M-0.06M
Change in Property, Plant and EquipmentChange in PP&E
0.17M-0.01M-0.01M-0.51M-0.74M-0.44M-0.02M222.00-3.46M-3.20M1.45M-1.45M1.65M-1.65M0.07M-0.11M
Change in IntangiblesChange Intangibless
0.05M-0.05M-0.25M0.50M
Sale and Maturity of InvestmentsInvestments Sold
-5.45M1.18M
Other Investing ActivitiesOther investing
0.72M-0.22M-0.11M-0.22M-0.01M-0.04M0.71M1.00M2.80M1.80M0.53M3.00M2.96M1.39M
Cash from Investing ActivitiesCash from Investing
-0.28M0.05M-0.11M11.91M-0.27M-0.02M0.74M-3.46M1.24M-1.35M-1.36M0.41M0.35M-2.89M-1.36M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
0.29M0.02M-0.30M1.01M3.11M0.96M1.27M0.01M2.73M
Long-Term Debt RepaymentsLT Debt Repayment
-335.000.14M
Non-Current Debt
335.00-0.14M0.29M0.02M-0.30M1.01M3.11M0.96M1.27M0.01M2.73M
Net Debt Issuances and RepaymentsNet Debt Issuance
335.00-0.14M0.29M0.02M-0.30M1.01M3.11M0.96M1.27M0.01M2.73M
Change in Capital Stock
Common Stock IssuedStock Issued
8,646.00M-8,645.98M34.000.30M1.84M7.05M1.49M0.05M0.15M439.000.34M5.40M2.48M
Shares Repurchased
1.47M0.23M0.22M-3.85M-2.96M5.92M-5.92M-7.17M7.17M
Net Shares Issued and RepurchasedNet Shares Issued
-1.47M-0.23M-0.22M3.85M8,648.96M-8,651.90M5.92M34.007.46M-5.32M7.05M1.49M0.05M0.15M439.000.34M5.40M2.48M
Net Equity Issued and RepurchasedNet Equity Issued
-1.47M-0.23M-0.22M3.85M8,648.96M-8,651.90M5.92M34.007.46M-5.32M7.05M1.49M0.05M0.15M439.000.34M5.40M2.48M
Other financing activitiesOther financing
0.01M-0.10M0.01M0.04M0.04M-0.24M-0.05M-0.05M-0.05M-0.03M-0.01M-0.01M0.00M-0.03M-0.02M-0.03M-0.01M-0.05M-0.02M-0.02M
Cash from Financing ActivitiesCash from Financing
-0.02M-0.01M1.49M0.28M0.26M-4.09M-3.00M-0.04M-0.05M-0.03M0.57M1.84M6.74M2.47M3.13M1.29M0.26M1.41M7.00M2.46M
Additional items
Change in Cash
-3.88M-4.06M-6.69M-6.77M-7.76M-0.88M-0.19M2.88M-2.48M-2.02M-1.05M1.46M2.44M-0.69M
Ending Cash Balance
39.32M35.26M28.57M31.62M23.75M16.98M9.22M5.67M3.63M2.76M1.33M3.31M3.12M6.00M3.52M1.50M6.00M6.00M4.34M3.65M
Free Cash FlowFCF
4.59M-37.40M5.11M9.39M7.50M-50.85M-4.75M-3.51M-2.46M-0.85M-2.00M-0.61M-6.92M-4.04M-3.08M-3.13M-2.18M-0.31M-1.67M-1.84M
Net Cash FlowNCF
4.29M-37.37M6.47M9.67M7.77M-42.52M-7.76M-3.55M-2.04M-0.88M-1.43M1.98M-0.19M2.88M-2.48M-2.02M-1.05M1.46M2.44M-0.69M
Interest Paid
0.00M0.03M0.02M0.02M0.02M0.01M0.00M0.01M0.01M0.00M0.01M0.01M-0.01M0.03M-0.03M0.07M0.04M

Quantum Biopharma Cash Flow Statement API

Pull Quantum Biopharma's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=QNTM&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY